An individual may become completely paralyzed because of any number of accidents that interfere with the functioning of the ...
Gene Expression Data Show Direct Impact on the Core Biology of IPF ...
Dietary taurine supplementation reduced neuroinflammation and pathology in Alzheimer’s disease models. Learn more about its ...
The 3.5 mm headphone jack has been in decline for many years, but if your phone still has one, you can use it for a lot more than just listening to music.
Machine learning decodes brain signals for paralysis recovery in just one second using sensors placed on scalp not inside ...
LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...
AZoLifeSciences on MSN
A week of 40-Hz sound triggers long-lasting amyloid changes in monkeys
Forty-hertz auditory stimulation in aged monkeys doubles CSF amyloid-β levels, offering insights into non-invasive strategies for Alzheimer's disease treatment.
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA acti ...
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) ...
Young and the Invested on MSN
12 core dividend stocks that pay up to 7.3%
This article discusses some of the best dividend stocks right now.
Detailed price information for Bright Minds Biosciences Inc (DRUG-CN) from The Globe and Mail including charting and trades.
An international team of researchers has systematically measured the β-decay half-lives of 40 nuclei near calcium-54, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results